These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30066731)

  • 1. Statistical analysis plan for early goal-directed therapy using a physiological holistic view - the ANDROMEDA-SHOCK: a randomized controlled trial.
    Hernández G; Cavalcanti AB; Ospina-Tascón G; Dubin A; Hurtado FJ; Damiani LP; Friedman G; Castro R; Alegría L; Cecconi M; Teboul JL; Bakker J
    Rev Bras Ter Intensiva; 2018; 30(3):253-263. PubMed ID: 30066731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.
    Hernández G; Ospina-Tascón GA; Damiani LP; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Granda-Luna V; Cavalcanti AB; Bakker J; ; Hernández G; Ospina-Tascón G; Petri Damiani L; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Cavalcanti AB; Bakker J; Hernández G; Alegría L; Ferri G; Rodriguez N; Holger P; Soto N; Pozo M; Bakker J; Cook D; Vincent JL; Rhodes A; Kavanagh BP; Dellinger P; Rietdijk W; Carpio D; Pavéz N; Henriquez E; Bravo S; Valenzuela ED; Vera M; Dreyse J; Oviedo V; Cid MA; Larroulet M; Petruska E; Sarabia C; Gallardo D; Sanchez JE; González H; Arancibia JM; Muñoz A; Ramirez G; Aravena F; Aquevedo A; Zambrano F; Bozinovic M; Valle F; Ramirez M; Rossel V; Muñoz P; Ceballos C; Esveile C; Carmona C; Candia E; Mendoza D; Sanchez A; Ponce D; Ponce D; Lastra J; Nahuelpán B; Fasce F; Luengo C; Medel N; Cortés C; Campassi L; Rubatto P; Horna N; Furche M; Pendino JC; Bettini L; Lovesio C; González MC; Rodruguez J; Canales H; Caminos F; Galletti C; Minoldo E; Aramburu MJ; Olmos D; Nin N; Tenzi J; Quiroga C; Lacuesta P; Gaudín A; Pais R; Silvestre A; Olivera G; Rieppi G; Berrutti D; Ochoa M; Cobos P; Vintimilla F; Ramirez V; Tobar M; García F; Picoita F; Remache N; Granda V; Paredes F; Barzallo E; Garcés P; Guerrero F; Salazar S; Torres G; Tana C; Calahorrano J; Solis F; Torres P; Herrera L; Ornes A; Peréz V; Delgado G; López A; Espinosa E; Moreira J; Salcedo B; Villacres I; Suing J; Lopez M; Gomez L; Toctaquiza G; Cadena Zapata M; Orazabal MA; Pardo Espejo R; Jimenez J; Calderón A; Paredes G; Barberán JL; Moya T; Atehortua H; Sabogal R; Ortiz G; Lara A; Sanchez F; Hernán Portilla A; Dávila H; Mora JA; Calderón LE; Alvarez I; Escobar E; Bejarano A; Bustamante LA; Aldana JL
    JAMA; 2019 Feb; 321(7):654-664. PubMed ID: 30772908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial.
    Zampieri FG; Damiani LP; Bakker J; Ospina-Tascón GA; Castro R; Cavalcanti AB; Hernandez G
    Am J Respir Crit Care Med; 2020 Feb; 201(4):423-429. PubMed ID: 31574228
    [No Abstract]   [Full Text] [Related]  

  • 4. Early goal-directed therapy using a physiological holistic view: the ANDROMEDA-SHOCK-a randomized controlled trial.
    Hernández G; Cavalcanti AB; Ospina-Tascón G; Zampieri FG; Dubin A; Hurtado FJ; Friedman G; Castro R; Alegría L; Cecconi M; Teboul JL; Bakker J;
    Ann Intensive Care; 2018 Apr; 8(1):52. PubMed ID: 29687277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol.
    Kattan E; Bakker J; Estenssoro E; Ospina-Tascón GA; Cavalcanti AB; Backer D; Vieillard-Baron A; Teboul JL; Castro R; Hernández G
    Rev Bras Ter Intensiva; 2022; 34(1):96-106. PubMed ID: 35766659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate: Where Are We Now?
    Bakker J; Postelnicu R; Mukherjee V
    Crit Care Clin; 2020 Jan; 36(1):115-124. PubMed ID: 31733674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Protocolised Management in Sepsis (ProMISe) trial statistical analysis plan.
    Power GS; Harrison DA; Mouncey PR; Osborn TM; Harvey SE; Rowan KM
    Crit Care Resusc; 2013 Dec; 15(4):311-7. PubMed ID: 24289513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between arterial blood lactate clearance, prognosis and myocardial damage in patients with septic shock after early goal-directed therapy].
    Shang XL; Liu DW; Wang XT; He HW; Zhang HM; Su LX; Pan P
    Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):345-350. PubMed ID: 29747290
    [No Abstract]   [Full Text] [Related]  

  • 10. The Australasian Resuscitation in Sepsis Evaluation (ARISE) trial statistical analysis plan.
    Delaney AP; Peake SL; Bellomo R; Cameron P; Holdgate A; Howe B; Higgins A; Presneill J; Webb S;
    Crit Care Resusc; 2013 Sep; 15(3):162-71. PubMed ID: 23944201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on perfusion monitoring in septic shock after the ANDROMEDA-SHOCK trial.
    Hernández G; Bakker J
    Med Intensiva (Engl Ed); 2019 Dec; 43(9):578-581. PubMed ID: 31694767
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical analysis plan for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART). A randomized controlled trial.
    Damiani LP; Berwanger O; Paisani D; Laranjeira LN; Suzumura EA; Amato MBP; Carvalho CRR; Cavalcanti AB
    Rev Bras Ter Intensiva; 2017; 29(2):142-153. PubMed ID: 28977255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Goal-Directed Therapy in Severe Sepsis and Septic Shock: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
    Lu Y; Zhang H; Teng F; Xia WJ; Sun GX; Wen AQ
    J Intensive Care Med; 2018 May; 33(5):296-309. PubMed ID: 27756870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the personalization of septic shock resuscitation: the fundamentals of ANDROMEDA-SHOCK-2 trial.
    Ramasco F; Aguilar G; Aldecoa C; Bakker J; Carmona P; Dominguez D; Galiana M; Hernández G; Kattan E; Olea C; Ospina-Tascón G; Pérez A; Ramos K; Ramos S; Tamayo G; Tuero G;
    Rev Esp Anestesiol Reanim (Engl Ed); 2024 Feb; 71(2):112-124. PubMed ID: 38244774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life and 1-Year Survival in Patients With Early Septic Shock: Long-Term Follow-Up of the Australasian Resuscitation in Sepsis Evaluation Trial.
    Higgins AM; Peake SL; Bellomo R; Cooper DJ; Delaney A; Harris AH; Howe BD; Nichol AD; Webb SA; Williams PJ;
    Crit Care Med; 2019 Jun; 47(6):765-773. PubMed ID: 30985391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australasian Resuscitation In Sepsis Evaluation trial statistical analysis plan.
    Delaney A; Peake SL; Bellomo R; Cameron P; Holdgate A; Howe B; Higgins A; Presneill J; Webb S;
    Emerg Med Australas; 2013 Oct; 25(5):406-15. PubMed ID: 24099368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock.
    Mouncey PR; Osborn TM; Power GS; Harrison DA; Sadique MZ; Grieve RD; Jahan R; Tan JC; Harvey SE; Bell D; Bion JF; Coats TJ; Singer M; Young JD; Rowan KM
    Health Technol Assess; 2015 Nov; 19(97):i-xxv, 1-150. PubMed ID: 26597979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lactate-targeted resuscitation strategy may be associated with higher mortality in patients with septic shock and normal capillary refill time: a post hoc analysis of the ANDROMEDA-SHOCK study.
    Kattan E; Hernández G; Ospina-Tascón G; Valenzuela ED; Bakker J; Castro R;
    Ann Intensive Care; 2020 Aug; 10(1):114. PubMed ID: 32845407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock: Analysis of the Protocol-Based Care for Early Septic Shock Study.
    Kellum JA; Pike F; Yealy DM; Huang DT; Shapiro NI; Angus DC;
    Crit Care Med; 2017 Mar; 45(3):438-445. PubMed ID: 28079606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan.
    Meyhoff TS; Hjortrup PB; Møller MH; Wetterslev J; Lange T; Kjaer MN; Jonsson AB; Hjortsø CJS; Cronhjort M; Laake JH; Jakob SM; Nalos M; Pettilä V; van der Horst I; Ostermann M; Mouncey P; Rowan K; Cecconi M; Ferrer R; Malbrain MLNG; Ahlstedt C; Hoffmann S; Bestle MH; Nebrich L; Russell L; Vang M; Rasmussen ML; Sølling C; Rasmussen BS; Brøchner AC; Perner A
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1262-1271. PubMed ID: 31276193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.